BR0308403A - Método para tratamento de um distúrbio do olho de um paciente humano ou veterinário, e, uso de um composto - Google Patents

Método para tratamento de um distúrbio do olho de um paciente humano ou veterinário, e, uso de um composto

Info

Publication number
BR0308403A
BR0308403A BR0308403-5A BR0308403A BR0308403A BR 0308403 A BR0308403 A BR 0308403A BR 0308403 A BR0308403 A BR 0308403A BR 0308403 A BR0308403 A BR 0308403A
Authority
BR
Brazil
Prior art keywords
corneal
eye
urea
compound
guanidinium
Prior art date
Application number
BR0308403-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Vicken Karageozian
David Castillejos
John Park
Gabriel Arthuro Carpio Aragon
Jose Luis Gutierres Flores
Original Assignee
Vitreo Retinal Technologies In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitreo Retinal Technologies In filed Critical Vitreo Retinal Technologies In
Publication of BR0308403A publication Critical patent/BR0308403A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR0308403-5A 2002-03-14 2003-03-14 Método para tratamento de um distúrbio do olho de um paciente humano ou veterinário, e, uso de um composto BR0308403A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36397902P 2002-03-14 2002-03-14
PCT/US2003/007700 WO2003077898A1 (en) 2002-03-14 2003-03-14 Agents for corneal or intrastromal administration to treat or prevent disorders of the eye

Publications (1)

Publication Number Publication Date
BR0308403A true BR0308403A (pt) 2005-01-18

Family

ID=28041849

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308403-5A BR0308403A (pt) 2002-03-14 2003-03-14 Método para tratamento de um distúrbio do olho de um paciente humano ou veterinário, e, uso de um composto

Country Status (10)

Country Link
EP (1) EP1482922A4 (ru)
JP (1) JP2005522464A (ru)
KR (1) KR20040094793A (ru)
CN (1) CN1642536A (ru)
AU (2) AU2003213858A1 (ru)
BR (1) BR0308403A (ru)
CA (1) CA2478965A1 (ru)
MX (1) MXPA04008776A (ru)
RU (1) RU2363459C2 (ru)
WO (1) WO2003077898A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030199574A1 (en) 2000-03-02 2003-10-23 Vitreo-Retinal Technologies, Inc. Treatment of ophthalmic disorders using urea and urea derivatives
CN101231121B (zh) * 2007-01-24 2012-06-13 泰州乐金电子冷机有限公司 冰箱用托盘拉出装置
WO2011111876A1 (en) * 2010-03-12 2011-09-15 Riken Clearing reagent for biological material, and use thereof
EP2711682B1 (en) 2011-05-20 2019-07-10 Riken Clarifying reagent for biological materials and use thereof
JP6433901B2 (ja) 2013-08-14 2018-12-05 国立研究開発法人理化学研究所 光透過性に優れた生物材料を調製するための組成物およびその利用
DE102013110608A1 (de) * 2013-09-26 2015-03-26 Florian Lang Substanz zur Hemmung von Gewebskalzifizierung, Gewebsfibrosierung und altersassoziierten Erkrankungen
CN110237238A (zh) * 2019-08-02 2019-09-17 山东省眼科研究所 Manf在促进角膜损伤修复中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470881A (en) * 1993-09-09 1995-11-28 West Virginia University Research Corporation Urea ophthalmic ointment and solution
JP2002538125A (ja) * 1999-03-02 2002-11-12 ビトレオ−レチナール テクノロジーズ インコーポレイテッド 眼の障害を治療又は予防するための硝子体内投与用薬剤
CA2475338C (en) * 2002-02-13 2014-08-19 Vitreo-Retinal Technologies, Inc. Treatment of ophthalmic disorders using urea and urea derivatives

Also Published As

Publication number Publication date
KR20040094793A (ko) 2004-11-10
EP1482922A1 (en) 2004-12-08
AU2003213858A1 (en) 2003-09-29
AU2009201897B2 (en) 2011-09-15
RU2004129761A (ru) 2005-06-10
JP2005522464A (ja) 2005-07-28
WO2003077898A1 (en) 2003-09-25
EP1482922A4 (en) 2005-06-08
CA2478965A1 (en) 2003-09-25
MXPA04008776A (es) 2005-04-19
CN1642536A (zh) 2005-07-20
AU2009201897A1 (en) 2009-06-04
RU2363459C2 (ru) 2009-08-10

Similar Documents

Publication Publication Date Title
DE60039043D1 (de) Mittel für intravitreale verabreichung zur behandlung oder vorbeugung von augenerkrankungen
ES2264197T3 (es) Dinucleotidos y sus usos.
NO943901D0 (no) Fremgangsmåter og preparater for behandling av sykdommer med interferon samtidig som bivirkninger reduseres
BR0309670A (pt) Compostos derivados dicetohidrazina e drogas contendo os compostos como o ingrediente ativo
BR0014525A (pt) Processo de tratamento de distúrbios metabólicos, especialmente diabetes, ou uma doença ou condição associada com diabetes
DE69706642D1 (de) Pyridylfuran- und Pyridylthiphenderivate und deren pharmazeutische Verwendung
BRPI0507675A (pt) derivados de 2&#39;-c-metil nucleosìdeo
AP1853A (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents.
BR9914097A (pt) Composto, uso do mesmo, composição farmacêutica e método de profilaxia ou tratamento de uma infecção viral e processo para preparação do composto
TR200200234T2 (tr) Tirozin Protein kinaz SYK purin türevleri inhibitörleri
BR0308403A (pt) Método para tratamento de um distúrbio do olho de um paciente humano ou veterinário, e, uso de um composto
Cronstein The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism
DK0658110T3 (da) Anvendelse af norastemizol til behandling af allergisk rhinitis
BRPI0410050A (pt) método de tratamento ou de profilaxia de distúrbios psicóticos, distúrbios de prejuìzo intelectual ou doenças ou condições nos quais a modulação do receptor alfa7-nicotìnico é benéfica, composição farmacêutica, método de tratamento ou de profilaxia de doenças, uso de um composto, composto, e, método de preparação de um composto
NO20023486D0 (no) Forbindelser av pyrroltypen, perapater inneholdende forbindelser samt deres anvendelse for behandling av cancer- ogvirale sykdommer
CA2468664A1 (en) Ketorolac tromethamine compositions for treating or preventing ocular pain
EP0286825A3 (en) Use of 3&#39;-fluro-3&#39; deoxythymidine for the manufacture of a medicament for the treatment of virus infections
DE60011637D1 (de) Dioxolan nukleosidanalogen zur behandlung und vorbeugung von viralen infektionen
DK0500953T3 (da) Potentiator af antineoplastisk virkning og antineoplastisk middel
BRPI0410878A (pt) derivados de benzotiazol e seus usos no tratamento de doenças relacionadas com o receptor a2a da adenosina
CO4940437A1 (es) 2-amino-7-(2-hidroxietileno 1-sustituido) -3,5-dihidropirro- lo 3,2-pirimidin-4-onas
Shinkai et al. Valacyclovir
BRPI0016329B8 (pt) bis-indolilmaleimidas substituídas para inibição de proliferação de células, seu processo de preparação e seu uso, bem como composição farmacêutica.
Srinivas Parthenium dermatitis treated with azathioprine weekly pulse doses
EP3572079B1 (en) Etamsylate for treatment of herpes virus infections

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: A61K 31/17, A61P 27/02, A61P 41/00

Ipc: A61K 31/17 (2011.01), A61P 27/02 (2011.01), A61P 4

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]